Literature DB >> 22098657

Complications of progression of CKD.

Min Yang1, Chester H Fox, Joseph Vassalotti, Michael Choi.   

Abstract

CKD is a complex comorbid condition with multiple manifestations. It is closely linked with cardiovascular disease and has a very high mortality rate. Currently, it consumes 28% of Medicare expenditures. Complications of CKD include hypertension, diabetes, dyslipidemia, cardiovascular disease, anemia, and bone and mineral disorders. It is underrecognized and underdiagnosed in primary care offices. There is strong evidence that controlling blood pressure, blood glucose, and use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in albuminuric patients, as well as referral to the nephrologist when glomerular filtration rate is <30 mL/min/1.73 m(2), is associated with lower mortality, better access to kidney transplantation, improved management of comorbidities, and less frequent use of catheters for dialysis and to lower mortality.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098657     DOI: 10.1053/j.ackd.2011.10.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  13 in total

1.  Corni Fructus Alleviates UUO-Induced Renal Fibrosis via TGF-β/Smad Signaling.

Authors:  Jin A Lee; Mi-Rae Shin; Seong-Soo Roh
Journal:  Biomed Res Int       Date:  2022-05-06       Impact factor: 3.246

2.  Suicidal erythrocyte death in end-stage renal disease.

Authors:  Majed Abed; Ferruh Artunc; Kousi Alzoubi; Sabina Honisch; Dorothea Baumann; Michael Föller; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2014-04-18       Impact factor: 4.599

3.  Retrotransposon insertion in the T-cell acute lymphocytic leukemia 1 (Tal1) gene is associated with severe renal disease and patchy alopecia in Hairpatches (Hpt) mice.

Authors:  Vishnu Hosur; Melissa L Cox; Lisa M Burzenski; Rebecca L Riding; Lynn Alley; Bonnie L Lyons; Anoop Kavirayani; Kimberly A Martin; Gregory A Cox; Kenneth R Johnson; Leonard D Shultz
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

4.  Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR study.

Authors:  Konstantinos Sombolos; Demitrios Tsakiris; John Boletis; Demetrios Vlahakos; Kostas C Siamopoulos; Vassilios Vargemezis; Pavlos Nikolaidis; Christos Iatrou; Eugene Dafnis; Konstantinos Xynos; Christos Argyropoulos
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

Review 5.  Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.

Authors:  Elisabeth Lang; Florian Lang
Journal:  Biomed Res Int       Date:  2015-03-04       Impact factor: 3.411

6.  Micronutrient Intakes and Incidence of Chronic Kidney Disease in Adults: Tehran Lipid and Glucose Study.

Authors:  Hossein Farhadnejad; Golaleh Asghari; Parvin Mirmiran; Emad Yuzbashian; Fereidoun Azizi
Journal:  Nutrients       Date:  2016-04-20       Impact factor: 5.717

7.  Potential Use of Autologous Renal Cells from Diseased Kidneys for the Treatment of Renal Failure.

Authors:  Sunil K George; Mehran Abolbashari; John D Jackson; Tamer Aboushwareb; Anthony Atala; James J Yoo
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

8.  Association between dietary patterns and chronic kidney disease in a middle-aged Chinese population.

Authors:  Shan-Shan Xu; Jun Hua; Yi-Qian Huang; Long Shu
Journal:  Public Health Nutr       Date:  2019-10-02       Impact factor: 4.022

9.  A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan.

Authors:  Ren-Yeong Huang; Yuh-Feng Lin; Sen-Yeong Kao; Yi-Shing Shieh; Jin-Shuen Chen
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

10.  Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate.

Authors:  Mohamed Siyabeldin E Ahmed; Majed Abed; Jakob Voelkl; Florian Lang
Journal:  BMC Nephrol       Date:  2013-11-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.